Saladax Biomedical Inc — Form D
Saladax Biomedical Inc of BETHLEHEM, PA, a company, filed a Form D exempt-offering notice with the SEC on 2013-09-10. The offering totals $22.9M, of which $22.9M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2013-09-10
- Form: D
- Accession: 0001140361-13-035557
- Industry: Biotechnology
- Exemptions: 06
- Total offering: $22.9M
- Amount sold: $22.9M
- Investors: 7
- Date of first sale: 2013-02-28
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-202644
Issuer
- Name: Saladax Biomedical Inc
- CIK: 0001418094
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Address: 116 RESEARCH DRIVE, BETHLEHEM, PA, 18015
- Phone: (610) 419-6731
Officers, directors & promoters (11)
| Name | Role | Location |
|---|
| Adrienne Choma | Director | Bethlehem, PA |
| Greg L Critchfield | Director | Bethlehem, PA |
| Edward L Erickson | Director | Durham, NC |
| Joel J Gross | Director | Bethlehem, PA |
| Kevin J Harter | Director | Bethlehem, PA |
| James J Hensel | Director | Bethlehem, PA |
| Enrico J Petrillo | Director | Bethlehem, PA |
| Salvatore J Salamone | Director | Bethlehem, PA |
| Adrienne Choma | Executive Officer | Bethlehem, PA |
| Kevin J Harter | Executive Officer | Bethlehem, PA |
| Salvatore J Salamone | Executive Officer | Bethlehem, PA |
Other filings by this issuer (1)
More